AG
RIGL icon

Aperio Group’s Rigel Pharmaceuticals RIGL Stock Holding History

Aperio Group’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$179K Buy
5,118
+841
+20% +$24.3K ﹤0.01% 2323
2020
Q3 		$103K Buy
4,277
+2,408
+129% +$59.1K ﹤0.01% 2317
2020
Q2 		$34K Sell
1,869
-1,322
-41% -$23.8K ﹤0.01% 2313
2020
Q1 		$50K Sell
3,191
-427
-12% -$9.09K ﹤0.01% 2279
2019
Q4 		$77K Buy
3,618
+427
+13% +$8.79K ﹤0.01% 2283
2019
Q3 		$60K Buy
3,191
+2,567
+411% +$53K ﹤0.01% 2274
2019
Q2 		$16K Buy
+624
New +$14.1K ﹤0.01% 2723
2014
Q3 		– Sell
-2,318
Closed -$84K – 1767
2014
Q2 		$84K Sell
2,318
-75
-3% -$2.55K ﹤0.01% 1692
2014
Q1 		$93K Buy
+2,393
New +$85.3K ﹤0.01% 1975
2013
Q4 		– Hold
0
– – – 1942

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Aperio Group's RIGL Position: Q4 2020 in Review

Aperio Group increased its Rigel Pharmaceuticals (RIGL) stake by 20% in Q4 2020, buying an estimated $24.3K and bringing the position to 5,118 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #2323.

Aperio Group first reported a position in RIGL in Q1 2014 and has held it in 9 quarters since. 149 funds tracked by Wall St. Rank hold RIGL as of Q4 2020.

  • Aperio Group held 5,118 shares of Rigel Pharmaceuticals worth $179K as of Q4 2020.
  • Aperio Group bought 841 Rigel Pharmaceuticals shares in Q4 2020, an estimated $24.3K.
  • Rigel Pharmaceuticals made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2323 holding.
  • Aperio Group first reported a position in Rigel Pharmaceuticals in Q1 2014 and has held it in 9 quarters since.
  • 149 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.